Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO

Generate Biomedicines logo

Generate Biomedicines, a Phase 3 biotech using an AI drug discovery platform to develop severe asthma therapies, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. Generate Biomedicines states that its AI-enabled...read more

Renaissance Capital's January IPO Market Update

EquipmentShare.com logo

The 2026 IPO market started the year on reasonably steady footing as nine listings raised a combined $2.6 billion in January. Despite a mounting backlog of startups indicating IPO plans this year, many initially stayed on the sidelines and let others test...read more

SPAC Apeiron Acquisition files for $70 million IPO, targeting international operations

Apeiron Acquisition Vehicle I, a blank check company targeting cross-border and international operations, announced terms for its IPO on Wednesday. The New York, NY-based company plans to raise $70 million by offering 7 million units at a price of $10. Each...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.